Despite groundbreaking technological innovations in biotech and medicine, Japan still faces challenges in becoming a world leader in biotech and medicine.
On Wednesday, October 12th, Nobel Prize Winner, Dr. Shinya Yamanaka will be the keynote speaker for a panel discussing these issues and how Silicon Valley entrepreneurship can help to bring this technology to market. He and a panel of senior executives and experts will discuss how Japan and Silicon Valley together can build the next biomedicine powerhouse.
Innovation Salons are periodic programs set in an intimate and interactive setting that explore current developments in Japan – U.S. innovation and entrepreneurship. These Salons, offered by the Japan Society of Northern California in cooperation with Stanford’s US-Asia Technology Management Center, complement the annual Japan – U.S. Innovation Awards Symposium held at Stanford University.
Shinya Yamanaka, Center for iPS Cell Research and Application
Professor Shinya Yamanaka is most recognized for his discovery of induced pluripotent stem cells (iPSC), which are differentiated cells that have been reprogrammed to the pluripotent state. He is Director of the Center for iPS Cell Research and Application (CiRA), which was founded in 2008 in response to his discovery, at Kyoto University and Senior Investigator at the Gladstone Institutes.
Since his breakthrough finding, he has been the recipient of many prestigious awards including the Albert Lasker Basic Medical Research Award, the 100th Imperial Prize and Japan Academy Prize, the Wolf Prize in Medicine and the Breakthrough Prize in Life Sciences. The significance of iPSC was culminated with Dr. Yamanaka being awarded the Nobel Prize in 2012.
Gary W. Cleary, Cape Theraputics
Dr. Gary W. Cleary is an accomplished entrepreneur and world renowned scientist in the field of drug delivery systems and polymer technologies, having founded and co-founded companies and held management positions at many of the leading pharmaceutical companies. He was a founder of Cygnus, Inc. and Corium International, Inc. and earlier held research and management positions at ALZA Corporation, Key Pharmaceuticals and Genentech, as well as the U.S. Public Health Service and the U.S. Food and Drug Administration. Dr. Cleary was among the first researchers to determine and investigate the development of drug delivery systems for large molecular weight biomolecules. Read more …
Thomas Novak, Cellular Dynamics International
Dr. Tom Novak is Vice President, Strategic Partnerships, at Cellular Dynamics International (CDI) – A FUJIFILM Company, the world’s leading supplier of stem cell-derived, terminally differentiated cells. In addition, he is the Principle Investigator on CDI’s $16M grant from the California Institute for Regenerative Medicine to reprogram samples from 3000 patients with a variety of multigenic disorders. Prior to joining CDI in 2012, Dr. Novak was Senior VP of Research and Development at Fate Therapeutics, a San Diego-based biotech developing small molecules and biologics to induce proliferation and differentiation of adult stem cells to replace tissue lost to aging or disease. Read more …
Robert Kneller, University of Tokyo
From 1988 to 1997, Professor Kneller worked in cancer research in the US National Institutes of Health and then was responsible for the clinical trial agreements under which NIH and private companies cooperate to develop NIH-discovered cancer therapies. In 1997, he went to Japan to study its system of industry-university cooperation and since 1998 has been a professor at the University of Tokyo doing research that compares in Japan and America the roles of entrepreneurship, intellectual property, and academic research funding in the development of university discoveries. Read more …
Richard B. Dasher, Stanford University
Dr. Richard Dasher has directed the US-Asia Technology Management Center since 1994 and served concurrently as Executive Director of the Center for Integrated Systems (now renamed as the Stanford SystemX Alliance) since 1998. He holds Consulting Professor appointments in the Departments of Electrical Engineering (technology management) and East Asian Studies (Japanese business). From 2004, Dr. Dasher became the first non-Japanese person to join the governance of a Japanese national university, serving on the Board of Directors of Tohoku University and continuing on their Management Council until 2011. He is a member of the Program Committee of the World Premier International Research Center Initiative (WPI) of MEXT and is on the international advisory committee to the Japan Science and Technology Agency.
Light appetizers and drinks provided
TO ATTEND AS MEMBER PRICE, JOIN HERE
No Refunds after Wednesday, October 5
On line registration closes at 9:55 a.m. on Wednesday, October 12
Walk-ins not accepted
The event venue has been provided by generous support from: